556 related articles for article (PubMed ID: 29559977)
1. Interrelation of Diet, Gut Microbiome, and Autoantibody Production.
Petta I; Fraussen J; Somers V; Kleinewietfeld M
Front Immunol; 2018; 9():439. PubMed ID: 29559977
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
3. Dietary tryptophan links encephalogenicity of autoreactive T cells with gut microbial ecology.
Sonner JK; Keil M; Falk-Paulsen M; Mishra N; Rehman A; Kramer M; Deumelandt K; Röwe J; Sanghvi K; Wolf L; von Landenberg A; Wolff H; Bharti R; Oezen I; Lanz TV; Wanke F; Tang Y; Brandao I; Mohapatra SR; Epping L; Grill A; Röth R; Niesler B; Meuth SG; Opitz CA; Okun JG; Reinhardt C; Kurschus FC; Wick W; Bode HB; Rosenstiel P; Platten M
Nat Commun; 2019 Oct; 10(1):4877. PubMed ID: 31653831
[TBL] [Abstract][Full Text] [Related]
4. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria.
Wekerle H
Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii68-ii75. PubMed ID: 27856664
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome and multiple sclerosis: New insights and perspective.
Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
[TBL] [Abstract][Full Text] [Related]
6. Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis.
Calvo-Barreiro L; Eixarch H; Montalban X; Espejo C
Autoimmun Rev; 2018 Feb; 17(2):165-174. PubMed ID: 29191793
[TBL] [Abstract][Full Text] [Related]
7. A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis.
Calvo-Barreiro L; Eixarch H; Ponce-Alonso M; Castillo M; Lebrón-Galán R; Mestre L; Guaza C; Clemente D; Del Campo R; Montalban X; Espejo C
Cells; 2020 Apr; 9(4):. PubMed ID: 32272791
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis.
Xu L; Zhang C; He D; Jiang N; Bai Y; Xin Y
Life Sci; 2020 Jul; 253():117747. PubMed ID: 32376270
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Berer K; Gerdes LA; Cekanaviciute E; Jia X; Xiao L; Xia Z; Liu C; Klotz L; Stauffer U; Baranzini SE; Kümpfel T; Hohlfeld R; Krishnamoorthy G; Wekerle H
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10719-10724. PubMed ID: 28893994
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis: Possibility of a gut environment-induced disease.
Sato W; Yamamura T
Neurochem Int; 2019 Nov; 130():104475. PubMed ID: 31152766
[TBL] [Abstract][Full Text] [Related]
11. Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.
Montgomery TL; Künstner A; Kennedy JJ; Fang Q; Asarian L; Culp-Hill R; D'Alessandro A; Teuscher C; Busch H; Krementsov DN
Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27516-27527. PubMed ID: 33077601
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome in multiple sclerosis: The players involved and the roles they play.
Shahi SK; Freedman SN; Mangalam AK
Gut Microbes; 2017 Nov; 8(6):607-615. PubMed ID: 28696139
[TBL] [Abstract][Full Text] [Related]
13. Disease of the holobiont, the example of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Med Clin (Barc); 2019 Feb; 152(4):147-153. PubMed ID: 30424933
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
15. B cells in spontaneous autoimmune diseases of the central nervous system.
Berer K; Wekerle H; Krishnamoorthy G
Mol Immunol; 2011 Jun; 48(11):1332-7. PubMed ID: 21146219
[TBL] [Abstract][Full Text] [Related]
16. Role of intestinal microbiota in the development of multiple sclerosis.
Castillo-Álvarez F; Marzo-Sola ME
Neurologia; 2017 Apr; 32(3):175-184. PubMed ID: 26383059
[TBL] [Abstract][Full Text] [Related]
17. CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Cantor JM
J Neuroimmunol; 2014 Sep; 274(1-2):230-3. PubMed ID: 25002078
[TBL] [Abstract][Full Text] [Related]
18. The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.
Mowry EM; Glenn JD
Neurol Clin; 2018 Feb; 36(1):185-196. PubMed ID: 29157399
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Non-immune Cells to Activation and Modulation of the Intestinal Inflammation.
Curciarello R; Canziani KE; Docena GH; Muglia CI
Front Immunol; 2019; 10():647. PubMed ID: 31024529
[TBL] [Abstract][Full Text] [Related]
20. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P
J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
